{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:31:05Z","timestamp":1786710665580,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.remnie.2026.500325","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:46:07Z","timestamp":1784735167000},"page":"500325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of [18F]PSMA-1007 PET\/CT in staging of prostate cancer: Influence of bone uptake and relationship with D\u2019Amico risk classification"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-2337","authenticated-orcid":false,"given":"S.S.","family":"Medina-Ornelas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Vargas-Ahumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hernandez-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chavez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ramirez-Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Leon-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barrientos-Priego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2026.500325_bib0005","series-title":"Registro Nacional de c\u00e1ncer. Inciedencia y mortalidad por c\u00e1ncer en M\u00e9xico","year":"2019"},{"key":"10.1016\/j.remnie.2026.500325_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.remnie.2026.500325_bib0015","author":"Ferlay"},{"issue":"6","key":"10.1016\/j.remnie.2026.500325_bib0020","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/cancers17061049","article-title":"The role of 18F PSMA-1007 PET\/CT in the staging and detection of recurrence of prostate cancer, a scoping review","volume":"17","author":"Armany","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.remnie.2026.500325_bib0025","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.remnie.2026.500325_bib0030","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection Prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.remnie.2026.500325_bib0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/cancers13040628","article-title":"Grading evolution and contemporary prognostic biomarkers of clinically significant prostate cancer","volume":"13","author":"Sopyllo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.remnie.2026.500325_bib0040","unstructured":"Prostate Cancer. https:\/\/uroweb.org\/guidelines\/prostate-cancer. [Accessed 14 May 2025]."},{"key":"10.1016\/j.remnie.2026.500325_bib0045","unstructured":"Prostate Cancer. NCCN Clinical Practice Guidelines in Oncology. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf. [Accessed 27 May 2025]."},{"issue":"4","key":"10.1016\/j.remnie.2026.500325_bib0050","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.juro.2007.11.061","article-title":"Mayo Clinic validation of the D\u2019amico risk group classification for predicting survival following radical prostatectomy","volume":"179","author":"Boorjian","year":"2008","journal-title":"J Urol"},{"issue":"20","key":"10.1016\/j.remnie.2026.500325_bib0055","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3390\/diagnostics14202327","article-title":"Focal unspecific bone uptake on [18F]PSMA-1007 PET: evaluation analog PROMISE criteria and validation via PET\/CT follow-Up","volume":"14","author":"Benecke","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.remnie.2026.500325_bib0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13550-021-00845-z","article-title":"Intraindividual comparison of [(68) Ga]-Ga-PSMA-11 and [(18)F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis","volume":"11","author":"Hoberuck","year":"2021","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.remnie.2026.500325_bib0065","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2967\/jnumed.118.215434","article-title":"Unspecific (18)F-PSMA-1007 bone uptake evaluated through PSMA-11 PET, bone scanning, and MRI triple validation in patients with biochemical recurrence of prostate cancer","volume":"64","author":"Seifert","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2026.500325_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209613","article-title":"Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET\/CT","volume":"13","author":"Hammes","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.remnie.2026.500325_bib0075","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1007\/s00259-021-05456-3","article-title":"Clinical insignificance of [(18)F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation","volume":"48","author":"Arnfield","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 2","key":"10.1016\/j.remnie.2026.500325_bib0080","doi-asserted-by":"crossref","first-page":"67S","DOI":"10.2967\/jnumed.116.186767","article-title":"Prostate-specific membrane antigen ligands for imaging and therapy","volume":"58","author":"Eiber","year":"2017","journal-title":"J Nucl Med"},{"issue":"10231","key":"10.1016\/j.remnie.2026.500325_bib0085","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"prostate-specific membrane antigen PET-CT in patients with high-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): a prospective, randomised, multi-centre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.remnie.2026.500325_bib0090","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2026.500325_bib0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00259-023-06424-9","article-title":"The potential role of osteoporosis in unspecific [(18)F]PSMA-1007 bone uptake","volume":"51","author":"Ninatti","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.remnie.2026.500325_bib0100","first-page":"57","article-title":"18F-PSMA-1007 PET\/CT versus 68Ga-PSMA-11 PET\/CT in patients with newly diagnosed prostate cancer or biochemical recurrence","volume":"61","author":"Calais","year":"2020","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.remnie.2026.500325_bib0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrurol.2016.26","article-title":"Current use of PSMA-PET in prostate cancer management","volume":"13","author":"Maurer","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.remnie.2026.500325_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2026.500325_bib0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2967\/jnumed.118.212233","article-title":"Detection efficacy of (18)F-PSMA-1007 PET\/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2026.500325_bib0120","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s00259-021-05424-x","article-title":"Focal unspecific bone uptake on [(18)F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging","volume":"48","author":"Grunig","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.remnie.2026.500325_bib0125","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.2967\/jnumed.117.190314","article-title":"(68)Ga-PSMA-11 PET\/CT in newly diagnosed prostate cancer: correlation of intraprostatic PSMA uptake with several clinical parameters","volume":"58","author":"Koerber","year":"2017","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.remnie.2026.500325_bib0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11307-016-0957-6","article-title":"PSMA-based [18F]DCFPyL PET\/CT is superior to conventional imaging for lesion detection in patients with metastatic prostate cancer","volume":"18","author":"Rowe","year":"2016","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"10.1016\/j.remnie.2026.500325_bib0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eururo.2020.11.043","article-title":"Is Prostate-Specific Membrane Antigen Positron Emission Tomography\/Computed Tomography Imaging Cost-effective in prostate cancer: an analysis informed by the proPSMA trial","volume":"79","author":"De Feria Cardet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2026.500325_bib0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2967\/jnumed.117.198119","article-title":"Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET\/CT","volume":"59","author":"Eiber","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2026.500325_bib0145","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.crad.2023.12.008","article-title":"Fluorine-18 prostate-specific membrane antigen-1007-avid indeterminate bone lesions in prostate cancer: clinical and PET\/CT features to predict outcomes and prognosis","volume":"79","author":"Luo","year":"2024","journal-title":"Clin Radiol"},{"issue":"10","key":"10.1016\/j.remnie.2026.500325_bib0150","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00259-017-3725-1","article-title":"Development of standardized image interpretation for 68Ga-PSMA PET\/CT to detect prostate cancer recurrent disease","volume":"44","author":"Fanti","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808926000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808926000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:37:03Z","timestamp":1786707423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808926000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S2253808926000558"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2026.500325","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of [18F]PSMA-1007 PET\/CT in staging of prostate cancer: Influence of bone uptake and relationship with D\u2019Amico risk classification","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2026.500325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2026.500325","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular.","name":"copyright","label":"Copyright"}],"article-number":"500325"}}